B&M shares rise 4% on improved outlook and broker backing

B&M European Value Retail shares rose 4% after RBC designated the discount retailer a top sector pick, citing an anticipated turnaround in like-for-like sales from Q1, supported by improved merchandising and easier comparables. RBC maintains an 'outperform' rating, highlighting B&M's strong balance sheet, potential for a £150 million share buyback, and stable post-Covid margins, suggesting the stock is well-positioned for re-rating given its approximate 8x 2025 earnings and over 5% dividend yield.

Analysis

B&M European Value Retail SA (LSE:BME) shares experienced a 4% increase to 282.95p following a bullish note from RBC, which designated the company a top sector pick and reiterated its 'outperform' rating. The broker anticipates a turnaround in like-for-like sales growth starting in the first quarter, driven by easier comparatives, better weather, and improved merchandising, further supported by a strategic shift in store manager incentives towards sales generation. RBC dismisses concerns of a structural margin decline, arguing that post-pandemic gains from larger basket sizes and scale benefits are sustainable. The company's strong balance sheet, with leverage in the middle of its target range, underpins the feasibility of significant shareholder returns. This positive outlook is combined with an attractive valuation, with the stock trading at approximately eight times 2025 earnings and offering a dividend yield above 5%, suggesting a clear path to a valuation re-rating if performance milestones are met.

Key Decisions for Investors

• Given the stock's valuation at ~8x 2025 earnings and a >5% dividend yield, investors may find the potential for a £150 million share buyback, which could add 5% to EPS, a compelling reason to consider a long position.
• The primary catalysts for a re-rating are a tangible recovery in like-for-like sales and the formal execution of the share buyback; these metrics should be monitored closely in upcoming company reports.
• While the outlook is positive, the thesis hinges on the company's ability to deliver on sales momentum, making the upcoming Q1 results a critical validation point for the broker's optimistic forecast.